Loading...

GSK plc

GLAXF•PNK
Healthcare
Drug Manufacturers - General
$18.60
$-0.51(-2.67%)

GSK plc (GLAXF) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.0/100

Key Financials

Market Cap75.1B
P/E Ratio18.14
EPS (TTM)$1.10
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 Week$21.46
1 Month$18.99
3 Months$16.73
1 Year Target$18.65

GLAXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GLAXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $18.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.14 and a market capitalization of 75.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;